Uterine Fibroids

specific

Centers

Active Trials

$23M

Cancer Funding

Top Centers for Uterine Fibroids(15)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	—	$5M	69.7
2	Sandra and Edward Meyer Cancer Center at Weill Cornell MedicineNew York, NY Active Research Program	Active Research Program	—	$5M	67.3
3	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program	Active Research Program	—	$3M	65.0
4	UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA NCI Comprehensive Active Research Program	Active Research Program	—	$2M	62.7
5	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD NCI Comprehensive Active Research Program	Active Research Program	—	$2M	60.3
6	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program	Active Research Program	—	$2M	58.0
7	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program	Active Research Program	—	$2M	55.7
8	Robert H. Lurie Comprehensive Cancer Center of Northwestern UniversityChicago, IL NCI Comprehensive Active Research Program	Active Research Program	—	$1M	53.3
9	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program	Active Research Program	—	$1M	51.0
10	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program	Active Research Program	—	$144K	48.7
11	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical		—	—	41.7
12	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical		—	—	41.7
13	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR		—	—	41.7
14	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX		—	—	41.7
15	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL		—	—	41.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →